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The Crb complex, first identified in Drosophila, is 
required for polarity and adhesion in embryonic epithelia, 
stalk membrane morphogenesis in photoreceptors and for the 
formation of adherens junctions between cells in the retina 
[1-3]. In mice and humans, the Crb complex is involved in 
retinal integration and organization [4,5].
The human crumbs homolog 1 (CRB1; Gene ID: 23418, 
OMIM: 604210) gene encodes a protein containing a signal 
peptide, 19 epidermal growth-factor (EGF) domains, three 
A-globular-like domains, and a transmembrane domain [6]. 
CRB1 is part of the protein complex at adhesion junctions 
(AJ) and localized to the external limiting membrane (ELM) 
in the retina. Mutations in the CRB1 gene are associated with 
phenotypically diverse retinal disorders including Leber 
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Presence of rd8 mutation does not alter the ocular phenotype of 
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Purpose: A spontaneous frameshift mutation, c.3481delC, in the Crb1 gene is the underlying cause of dysplasia and 
retinal degeneration in rd8 mice. The rd8 mutation is found in C57BL/6N but not in C57BL/6J mouse sub-strains. The 
development of ocular pathology in single knockout Ccl2−/−, Cx3cr1−/− and in double knockout Ccl2−/−/Cx3cr1−/− mice 
raised on a C57BL/6 background has been reported to depend on the presence of a rd8 mutation. In this study, we inves-
tigated the influence of the rd8 mutation on the retinal pathology that we previously described in the late-onset retinal 
degeneration (L-ORD) mouse model with a heterozygous S163R mutation in the C1q-tumor necrosis factor-related 
protein-5 (Ctrp5+/−) gene that was generated on a C57BL/6J background.
Methods: Mouse lines carrying the Ctrp5 S163R and rd8 mutations (Ctrp5+/−;rd8/rd8), corresponding controls without the 
rd8 mutation (Ctrp5+/−;wt/wt), and wild-type mice with and without the rd8 mutation (Wtrd8/rd8 and Wtwt/wt, respectively) were 
generated by systematic breeding of mice in our L-ORD mouse colony. Genotyping the mice for the rd8 (del C at nt3481 
in Crb1) and Ctrp5 S163R mutations was performed with allelic PCR or sequencing. Retinal morphology was studied 
with fundus imaging, histology, light microscopy, electron microscopy, and immunohistochemistry.
Results: Genotype analysis of the mice in L-ORD mouse colony detected the rd8 mutation in the homozygous and 
heterozygous state. Fundus imaging of wild-type mice without the rd8 mutation (Wtwt/wt) revealed no autofluorescence 
(AF) spots up to 6–8 months and few AF spots at 21months. However, the accumulation of AF lesions accelerated with 
age in the Ctrp5+/− mice that lack the rd8 mutation (Ctrp5+/−;wt/wt). The number of AF lesions was significantly increased 
(p<0.001), and they were small and uniformly distributed throughout the retina in the 21-month-old Ctrp5+/−;wt/wt mice 
when compared to the age-matched controls. Wild-type and Ctrp5+/− mice with the rd8 mutation (Wtrd8/rd8 and Ctrp5+/−;rd8/
rd8, respectively) revealed an integrated retinal architecture with well-defined outer segments/inner segments (OS/IS), 
outer nuclear layer (ONL), outer plexiform layer (OPL), and inner nuclear layer (INL). The presence of pseudorosette 
structures reported in the rd8 mice between the ONL and the INL in the ventral quadrant of the retina was not observed 
in all genotypes studied. Further, the external limiting membrane was continuous in the Ctrp5+/−;rd8/rd8 and Wtrd8/rd8 mice. 
Evaluation of the retinal phenotype revealed that the Ctrp5+/−;wt/wt mice developed characteristic L-ORD pathology 
including age-dependent accumulation of AF spots, development of sub-retinal, sub-RPE, and basal laminar deposits, 
and Bruch’s membrane abnormalities at older age, while these changes were not observed in the age-matched littermate 
WTwt/wt mice.
Conclusions: The Wtrd8/rd8 and Ctrp5+/−;rd8/rd8 mice raised on C57BL/6J did not develop early onset retinal changes that are 
characteristic of the rd8 phenotype, supporting the hypothesis that manifestation of rd8-associated pathology depends 
on the genetic background. The retinal pathology observed in mice with the Ctrp5+/−;wt/wt genotype is consistent with the 
L-ORD phenotype observed in patients and with the phenotype we described previously. The lack of rd8-associated 
retinal pathology in the Ctrp5+/−;wt/wt mouse model raised on the C57BL/6J background and the development of the L-
ORD phenotype in these mice in the presence and absence of the rd8 mutation suggests that the pathology observed in 
the Ctrp5+/−;wt/wt mice is primarily associated with the S163R mutation in the Ctrp5 gene.
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congenital amaurosis (LCA), early onset retinitis pigmentosa 
(e.g., RP12), retinitis pigmentosa with coats-like exudative 
vasculopathy, and pigmented paravenous retinochoroidal 
atrophy [7-13]. Four percent of patients with autosomal reces-
sive retinitis pigmentosa (arRP) and 10–15% of patients with 
autosomal recessive Leber congenital amaurosis (arLCA) 
carry mutations in the CRB1 gene [9-11]. The phenotypic 
diversity of the patients who carry CRB1 mutations has led 
to the hypothesis that environmental and genetic modifiers 
influence the severity and presentation of CRB1-associated 
retinal degeneration [11,14,15].
The naturally occurring retinal degeneration 8 (rd8) 
mouse model carries a homozygous single base deletion 
(c.3481delC) in Crb1 (Crb1rd8/rd8) causing early onset retinal 
degeneration, retinal folds, pseudorosettes, focal retinal 
dysplasia, and ocular spots [5]. The ocular spots correspond 
to the retinal folds and pseudorosettes that form due to abnor-
mality in the adherens junctions between the photoreceptors 
and the Müller glia (MG) cells. The outer nuclear layer (ONL) 
and the inner nuclear layer (INL) are affected in rd8 mice. 
The deletion causes a frameshift resulting in a truncated 
Crb1 protein that consists of only the N-terminal extracellular 
domain [16].
Similar to patients carrying CRB1 mutations, pheno-
typic variations are observed between and within mice 
strains homozygous for the rd8 mutation [17]. It has also 
been reported that the C57BL/6 lines provided by several 
commercial vendors harbor the rd8 mutation and present 
the characteristic Crb1-associated phenotype [17]. Although 
rd8 mice of the naturally occurring strain (Crb1rd8/rd8) exhibit 
ocular spots in the inferior nasal quadrant, the eyes of mice 
with the rd8 mutation on the CAST/EiJ background (CAST/
EiJrd8/rd8) are reported to have fewer spots than the naturally 
occurring strain [5]. About 19% of the CAST/EiJrd8/rd8 mice 
do not develop ocular spots. Furthermore, N7 generation 
of Crb1rd8/rd8 backcrossed with C57BL/6J did not develop 
retinal spots [5]. The retinal histology of the C57BL/6J mice 
homozygous for the rd8 mutation are normal, lacking retinal 
folds and photoreceptor inner segment (IS) disorganiza-
tion suggesting that the C57BL/6J background is a strong 
modulator of the rd8 phenotype. In contrast, C57BL/6N, a 
sub-strain derived from C57BL/6J after 1951, harbors the 
rd8 mutation and invariably expresses the characteristic 
Crb1-associated phenotype [17]. The discrepancies in the rd8 
phenotype between and within mouse strains provide clear 
evidence that genetic modifiers influence the development 
of rd8 pathology. Two genetically related homozygous rd8 
mouse lines obtained from a backcross with C57BL/6JOlaHsd 
mice display variable phenotypes, and a genetic factor on 
chromosome 15 has been suggested to be responsible for this 
variation [18].
The early onset ocular phenotypes observed in HLA-A29 
transgenic mice and CCDKO mice are associated with pres-
ence of the rd8 mutation and are not due to mutations in the 
HLA-A29, Ccl2, or Cx3cr1 gene [17]. HLA-A29 transgenic 
and CCDKO mice carrying the rd8 mutation in the homo-
zygous state exhibit retinal dysplasia. Interestingly, about 
20–25% of the HLA-A29 transgenic mice with the rd8 muta-
tion in the heterozygous state also develop dysplasia [17,19]. 
The genetic background of the rd8 mutation differentially 
modulates the retinal phenotype in the original CCDKO and 
the rederived Ccl2−/−, Cx3cr1−/−, and Ccl2−/−/Cx3cr1−/− double-
knockout mice. The early onset retinal degeneration seen in 
Ccl2−/−/Cx3cr1−/− double-knockout mice are dependent on the 
rd8 mutation, rather than the synergistic effect of both muta-
tions [19].
We previously reported the ocular phenotype of a knock-
in mouse model for late-onset retinal degeneration (L-ORD) 
caused due to a heterozygous S163R mutation in the Ctrp5 
gene [20]. These mice develop a late-onset retinal degenera-
tion phenotype resembling the clinical phenotype observed in 
patients with L-ORD, including slower rod b-wave recovery, 
RPE abnormalities, drusen, Bruch’s membrane abnormalities 
including basal laminar deposits, predominant cone photo-
receptor loss with onset around age 13 months, followed by 
rapid progression of retinal degeneration to near complete loss 
of cones by 21 months, and an age-dependent accumulation 
of hyperfluorescent spots [21-23]. Because the L-ORD mouse 
model (with Ctrp5+/− genotype) was developed using embry-
onic stem (ES) cells from mixed C57BL/6J and C57BL/6N 
strains and maintained on a C57BL/6J background, we 
investigated if the rd8 mutation is present in our colonies 
and whether it influenced the retinal phenotype associated 
with the Ctrp5 S163R mutation. The L-ORD mouse model 
(Ctrp5+/−;rd8/rd8 and Ctrp5+/−; wt/wt) and the wild-type littermate 
controls (Wt rd8/rd8 and Wt wt/wt) were evaluated for the presence 
of the rd8 mutation and its associated phenotype.
METHODS
Animals: The L-ORD mice were generated using ES cells 
derived from mixed C57BL/6J and C57BL/6N strain back-
ground mice [20]. These mouse lines were expanded by 
crossing with the C57BL/6J strain obtained from Jackson 
Laboratories (Bar Harbor, ME) to maintain the line. Mice 
with the desired genotype were generated for the current 
study by selectively breeding the mice in our L-ORD mice 
colony to generate the required genotypes. All studies were 
performed using L-ORD mice and wild-type (WT) littermate 
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mice of age groups 6–8, 9–11, 12–14, and 20–21 months. Five 
mice of each group were used for autofluorescent-scanning 
laser ophthalmoscopy (AF-SLO) imaging analyses; three to 
five mice were used for light microscopy and immunohisto-
chemistry (as described below in the Funduscopy section). 
All mice were maintained according to the ARVO Statement 
for the Use of Animals in Ophthalmic and Vision Research 
and with protocols approved by UCSD Institutional Animal 
Care and Use Committee.
Detection of the rd8 mutation with allele-specific PCR and 
sequencing: The mice were genotyped, as described previ-
ously [17,20]. Mouse tail DNA was isolated with Qiagen 
reagents following the manufacturer’s instructions (Gentra 
Puregene Mouse Tail Kit, Qiagen, Valencia, CA). Genotyping 
and sequencing for the Crb1 c.3481delC and Ctrp5 S163R 
mutations were performed using the primers described in 
Table 1.
The allele-specific PCR was performed using mCrb1mF1, 
mCrb1mF2, and mCrb1mR primers as described earlier [5]. 
The PCR reaction was carried out in a 20 μl reaction volume 
containing 1.5 mM MgCl2, 100 μM of each dNTP, 1.6 μM 
each of forward and reverse primer for Wt allele and 0.8 μM 
of forward and 1.6 μM of reverse primer for rd8 mutate allele 
with 0.026U AmpliTaq DNA polymerase. Approximately 
25 ng of DNA was taken for the reaction. The PCR reaction 
was initially denatured at 94 °C for 5 min followed by 35 
cycles at 94 °C for 30 s, 56 °C for 30 s, 72 °C for 30 s with 
a final extension of 72 °C for 7 min. Amplification of the 
wild-type allele produces a 220 bp fragment, and the mutant 
allele produces a 240 bp fragment. Confirmation of the rd8 
mutation was performed by sequencing the amplicons [17]. 
Genotyping for the Ctrp5 S163R knock-in mutation was 
performed as described earlier [20].
Fundoscopy: Fundoscopy and autofluorescence (AF) imaging 
were performed using a SPECTRALIS high-resolution, using 
a SPECTRALIS high-resolution, combination scanning 
laser ophthalmoscope and spectral domain optical coher-
ence tomography (HRA+OCT) imaging system (Heidelberg 
Engineering, Inc., Carlsbad, CA) as previously described 
[20,24-26]. The number of AF spots per eye was counted, 
and the average number of AF spots per fundus in each group 
were calculated.
Retinal histology: L-ORD (n=5) and WT (n=5) mice with 
and without the rd8 mutation were enucleated and the eyes 
fixed with the immersion fixation method using 2% para-
formaldehyde and 2% glutaraldehyde in 0.1 M phosphate 
buffer. Eyecups were postfixed in osmium-tannic acid-para-
phenylenediamine to preserve neutral lipids [27] before being 
embedded in Epon 812 per our published methods [28]. Thin 
sections were examined on a JEM 1200EX II electron (JOEL 
USA, Inc. Peabody, MA) microscope. Additional eyecups 
were embedded in methacrylate [17]. Sections (8–10 µm) 
were stained with hematoxylin and eosin and examined under 
a light microscope at 20X magnification. Retina cryosections 
(8–10 μm), obtained from the eyes fixed in 2% paraformal-
dehyde, were stained for β-catenin using specific antibodies 
and images were captured with an Olympus FV1000 confocal 
microscope.
Antibodies: S-opsin antibodies, goat polyclonal (1:200 Chem-
icon, Temecula, CA), and M-opsin antibody rabbit polyclonal 
(1:200, Chemicon) were obtained from a commercial source. 
The anti-mouse secondary antibody conjugated to Alexa 
fluor 555 and Alexa fluor 488 (1:1,000, Life Technologies, 
Grand Island, NY) were used to detect the protein expres-
sion with immunohistochemistry. β-catenin antibody (1:200; 
Santa Cruz Biotechnology Inc., Santa Cruz, CA) was used to 
check the integrity of the external limiting membrane (ELM).
Table 1. PCR PRimeR foR genoTyPing Wt wT/wT,WtRd8/Rd8, Ctrp5+/−,rd8/rd8 miCe 
and foR amPlifiCaTion of rd8 loCus foR sequenCing.
Gene Allele Primer name Sequence (5′-3′)
Crb1 Wild-type 3663-mCrb1 mF1 GTGAAGACAGCTACAGTTCTGATC
3665-mCrb1 mR GCCCCATTTGCACACTGATGAC




Crb1 rd8 3666-Crb-F GGTGACCAATCTGTTGACAATCC
3667-Crb-R GCCCCATTTGCACACTGATGAC
Ctrp5 Knock-in 2855-Ctrp5-F CCCCTACCTTTCGACCGT
2856-Ctrp5-R GAAGAAAGAGGCGATGGACTG
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Statistical analysis: Statistical significance between the 
number of AF spots in the mutant and wild-type mice was 
determined using the two-tailed, independent Student t test.
RESULTS
Detection of the rd8 mutation in L-ORD and WT mice: Anal-
ysis of mice in the L-ORD mouse model colony revealed the 
presence of the rd8 mutation. The location and identity of the 
mutation were confirmed with dideoxy sequencing (Figure 
1A). In the L-ORD mouse model colony, the rd8 mutation 
Figure 1. Detection of the rd8 muta-
tion with sequencing and agarose 
gel analysis. A: Sequence of the 
Crb1 locus showing the wild-type 
and the c.3481delC mutant allele in 
the homozygous state. The asterisk 
denotes the deletion. B: Agarose gel 
electrophoresis showing the migra-
tion of PCR amplicons for the rd8 
locus from Wt mice (220 bp), mice 
heterozygous (244 bp and 220 bp) 
and homozygous (244 bp) for the 
rd8 mutation. The DNA ladder 
was included to indicate the size of 
amplicons. Wtwt/wt, Crb1 wild-type; 
Wtwt/rd8, heterozygous for the Crb1 
mutation; Wtrd8/rd8, homozygous for 
the Crb1 mutation.
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was detected in the L-ORD mice and the WT littermate 
controls (Figure 1B). The majority of the mice carried the 
rd8 mutation in the homozygous or heterozygous state, while 
a minor proportion were negative for the rd8 mutation.
Ocular phenotype of L-ORD (Ctrp5+/−;wt/wt) and WT litter-
mate control (Wtwt/wt) mice: The presence of ocular spots is a 
common finding in L-ORD and rd8 mice strains. AF-SLO 
was used to document the ocular phenotype of Ctrp5+/−;wt/wt 
mice (n=5) and age-matched littermates Wtwt/wt (n=5; Figure 
2). Autofluorescent spots were not observed in the 6- to 
8-month-old and 9- to 11-month-old WTwt/wt mice (0±0). Few 
spots were visualized in the 12- to 14-month-old and 20- to 
21-month-old WTwt/wt mice (23±7 and 70±26, respectively). 
In contrast, the Ctrp5+/−;wt/wt mice displayed more spots by 
12–14 months (116±72). The accumulation of AF spots in the 
Ctrp5+/−;wt/wt mice was accelerated with age and increased 
several fold by 20–21 months (1569±105). The AF spots were 
small and round and distributed evenly throughout the retina 
in the Ctrp5+/−;wt/wt mice.
Retinal morphology of Ctrp5+/−;wt/wt, Wtwt/wt, and Wtrd8/rd8 mice: 
Retinal morphology was studied to evaluate the integrity of 
the retinal tissue. The gross retinal morphology of the Wtrd8/
rd8 mice was compared with the Wtwt/wt mice in our L-ORD 
mouse colony (Figure 3). Both sets of wild-type mice showed 
normal retinal morphology and lacked the changes associated 
with the rd8 genotype at 8 months of age. The INL, ONL, 
outer plexiform layer (OPL), and outer segments (OS) were 
normal in these mice. In addition, pseudorosette structures 
in the OPL and sub-retinal space that are prominent charac-
teristic features of the rd8 phenotype were absent in all mice.
The retinal architecture of the Ctrp5+/−;wt/wt mice was 
studied up to 21 months and compared with the phenotype 
of the age-matched Wtwt/wt littermate control mice (Figure 4). 
Under light microscopy, these mice did not show significant 
morphological changes including the abnormalities typically 
associated with the rd8 phenotype.
Ultrastructural analysis of the RPE was performed on 
Ctrp5+/−;wt/wt mice (n=3) at 9, 14, and 21 months. The Wtwt/wt 
mice (n=3) aged 21 months were used as a control to compare 
the pathology (Figure 5). The Wtwt/wt mice had normal RPE 
with well-organized basal infoldings and an intact Bruch’s 
membrane. RPE abnormalities were prominent as early as 9 
months in the Ctrp5+/−;wt/wt mice. The RPE basal infoldings 
were disorganized and displaced from Bruch’s membrane. 
Numerous vacuoles and phagolysosomes were found 
throughout the cytoplasm, and several packets of undigested 
membranous debris were found in the basal RPE. Focal 
basal laminar deposits and basal linear deposits were found 
in Bruch’s membrane by 14 months. The same abnormalities 
were also found in the 21-month-old Ctrp5+/−;wt/wt mice.
External limiting membrane is continuous in Ctrp5+/−; rd8/
rd8 mouse: To determine whether the loss of Crb1 affects 
ELM integrity, we studied the localization of β-catenin in 
the Ctrp5+/−;wt/wt and Ctrp5+/−;rd8/rd8 mice and compared its 
localization with the Wtwt/wt mouse retina. The anti-β-catenin 
antibody strongly stained the ELM in all mice including those 
with the rd8 mutation (Figure 6), and the pattern of staining 
indicated the presence of continuous ELM not only in the 
Wtwt/wt mice but also in the mice that had the rd8 mutation. 
These results demonstrate the presence of a continuous ELM.
Analysis of previously published Ctrp5+/− mice and WT 
controls for the rd8 genotype and phenotype: Systematic 
analysis of the Ctrp5+/− mice and their littermate controls was 
previously described by Chavali et al. [20]. Recent analysis 
of the tail DNA of the mice reported in Chavali et al. [20] for 
the Crb1 mutation revealed that the WT and Ctrp5+/− mice 
presented in that study had the rd8 genotype either in the 
heterozygous or homozygous state (Table 2). A review of 
retinal morphology of these mice presented in that publication 
revealed a lack of the characteristic features of rd8 pathology 
in the Ctrp5+/− mice and the WT littermate controls up to 21 
months [20]. Specifically, pseudorosettes were absent, and 
morphological changes suggestive of abnormal ELM were not 
observed. Ultrastructure analysis showed no abnormalities 
in the retina of the littermate control mice carrying the rd8 
mutation up to 21 months (Table 2) [20]. The retinal ultra-
structure of the Ctrp5+/− mice also had no apparent pathology 
until 5 months of age. However, in mice older than 12 months, 
the IS of the rods and cones were mildly swollen.
DISCUSSION
Analysis of our L-ORD mouse colony on a C57BL/6J back-
ground revealed the presence of the rd8 mutation [20]. In 
contrast to the findings reported in the original rd8 strain 
[5], Wtwt/wt, Wtrd8/rd8, and Ctrp5+/−; rd8/rd8 mice in our L-ORD 
mouse colony failed to exhibit the abnormal ocular pathology 
associated with the rd8 mutation up to 21 months of age, the 
longest time point presented in this study. In addition, the 
Ctrp5+/− mice free of the rd8 mutation developed the charac-
teristic L-ORD-associated pathology.
The rd8 mice were reported to develop AF lesions that 
were detected as early as 3 weeks of age [5]. These lesions 
were large, irregular, and heavily concentrated in the infe-
rior nasal quadrant of the fundus. Clinically, these lesions 
correspond to the region with retinal folds and pseudorosettes 
that involve the photoreceptors [29]. The laminar folds and 
pseudorosettes in rd8 mice were visualized between the ONL 
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Figure 2. Autofluorescence SLO fundus images of L-ORD mice lacking the rd8 mutation. A: Representative autofluorescent-scanning laser 
ophthalmoscopy (AF-SLO) images of C57BL/6 wild-type control mice free of the rd8 mutation (Wtwt/wt) and late-onset retinal degeneration 
(L-ORD) mice free of the rd8 mutation (Ctrp5+/−;wt/wt). The Wtwt/wt mice showed few AF spots by 21 months. However, the AF spots were 
significantly increased in the Ctrp5+/−;wt/wt mice by 21 months of age. Magnification bar=200 μm. B: Quantification of the AF spots in Wtwt/wt 
(black triangle) and Ctrp5+/−;wt/wt (black diamond) per the AF-SLO images. The number of AF spots is shown as the mean number of spots ± 
SD. There was an age-related increase in AF spots (linear regression plot) in both genotypes. However, the AF spots accumulated to a high 
number in L-ORD mice by 21 months when compared to the age-matched control mice (p<0.001).
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Figure 3. Histological analysis of 
the retina structure of 8-month-old 
Wtwt/wt and Wtrd8/rd8 mice. The retinas 
from 8-month-old Wtwt/wt and Wtrd8/
rd8 mice showed no dysplasia. 
mo, month; RPE, retinal pigment 
epithelium; OS, outer segment; 
IS, inner segment; ELM, external 
limiting membrane; ONL, outer- 
nuclear layer; OPL, outer plexiform 
layer; INL, inner nuclear layer; IPL, 
inner plexiform layer; GCL, glial 
cell layer. Magnification bar=2 μm.
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and the INL. Morphologically, they represent displacement 
of the IS/OS material and the photoreceptor cell bodies into 
the inner retina due to the incomplete formation of the ELM 
and loss of the structural barrier [29]. The photoreceptor IS 
lose their orderly arrangement, and by 4 weeks of age, 25% 
of photoreceptors are short in the rd8 mice when compared to 
WT mice [5]. A significant thinning of the IS and OS in the 
region with dysplasia was reported in rd8 mice by 4 weeks 
of age. By 10 weeks, photoreceptor OS in rd8 mice start to 
fragment resulting in the accumulation of granular debris in 
the sub-retinal space [5].
In contrast to the findings in the original colony of rd8 
mice, the Wtrd8/rd8 and Ctrp5+/−; rd8/rd8 mice in our L-ORD 
mouse colony did not show pseudorosette pathology even at 
21 months of age, the oldest age tested in this study. The 
histology of the mice in the L-ORD colony was devoid of the 
characteristic features of the rd8 phenotype. The Wtrd8/rd8 and 
Ctrp5+/−; rd8/rd8 mice showed well-defined nuclear layers (the 
INL and the ONL). The characteristic retinal changes that are 
prominent in rd8 mice as early as 4 weeks were not observed 
in either the Wtrd8/rd8 or Ctrp5+/-; rd8/rd8 mice in our colony of 
L-ORD mice at least up to age 21 months.
The L-ORD mouse model develops AF lesions around 12 
months with a subsequent progressive increase in the number 
of these lesions with age [20]. Contrary to the large number 
of AF lesions detected in Ctrp5+/−;wt/wt mice at older ages, a 
minimal number of spots were observed in the age-matched 
Wtwt/wt mice. Although AF lesions in 21-month-old Ctrp5+/−;wt/
wt were distributed throughout the retina, the ocular spots 
observed in the rd8 model were larger, heavily concentrated 
in the inferior quadrant of the fundus, and developed as 
early as 3 weeks of age. The rd8 mice backcrossed onto the 
C57BL/6 background were reported to have a discontinuous 
ELM phenotype [5]. In contrast, the Wtrd8/rd8 and Ctrp5+/−;rd8/
rd8 mice raised on the C57BL/6J background exhibited an 
uninterrupted outer limiting membrane. These observations 
indicate that the presence of the Crb1 mutation in either the 
homozygous or heterozygous state failed to result in the 
development of the characteristic rd8 phenotype in the Wtrd8/
rd8 and Ctrp5+/-; rd8/rd8 mice in our L-ORD mouse colony. A 
review of retinal morphology and analysis of the genotype 
Figure 4. Histological analysis of 
the retinal structure of the L-ORD 
mice. Retinal changes typically 
associated with the rd8 phenotype 
were not observed in either the 
Ctrp5+/−;wt/wt or Wt wt/wt mice at 
20–21 months. In addition, the 
retinal morphology of these mice 
lacked gross abnormalities that can 
be detected with light microscopy. 
Magnification bar=20 μm.
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Figure 5. Ultrastructural analysis of RPE and sub-RPE areas from Wtwt/wt and Ctrp5+/− ;wt/wt mice. Areas enclosed in boxes in A–D are magni-
fied in panels E–H. RPE from control mice (A, E) showed no abnormalities at 21 months of age. The RPE basal infoldings are organized 
(star), the cytoplasm is homogenous, and Bruch’s membrane is intact (bracket). In contrast, the RPE of the Ctrp5+/−,wt/wt mice (B, C, D, F, 
G, H) has structural aberrations beginning at 9 months of age. The RPE basal infoldings are disorganized (stars). Numerous packets of 
undigested membranous debris are found in the basal RPE (black arrowheads). Multiple vacuoles (white arrows) and phagolysosomes (black 
arrows) are found throughout the cytoplasm. Focal basal laminar deposits (white arrowheads) are present in Bruch’s membrane, as are basal 
linear deposits (asterisks). All marking are identical to those used in all panels. Magnification bars=200 μm in the top row and 500 μm in 
the bottom row.
Figure 6. Continuous ELM staining 
with anti-adherence junction 
marker in L-ORD mice homozy-
gous for the rd8 mutation. A–F are 
stained with anti-β-catenin. A, D: 
Retinal specimen from rd8 free 
wild-type control mouse (Wtwt/wt) 
at 9 months of age. B, E: Retinal 
specimen from a 5-month-old 
late-onset retinal degeneration 
(L-ORD) mouse lacking the rd8 
mutation (Ctrp5+/−;wt/wt). C, F: 
Retinal specimen from a 12-month-
old L-ORD mouse homozygous for 
the rd8 mutation (Ctrp5+/−;rd8/rd8). 
Continuous staining is observed across the ELM in all genotypes. The arrows indicate the ELM. Magnification bar=4 μm. ELM, external 
limiting membrane, ONL, outer nuclear layer, INL, internal nuclear layer.
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of previously published L-ORD mice and wild-type controls 
revealed the absence of the rd8-associated phenotype at least 
up to 21 months [20].
In contrast to the findings in the L-ORD mice, the retinal 
pathology in the rd8 model is clearly evident by 4 weeks with 
shortening and swelling of the IS and OS in rd8 mice [5]. 
Abnormalities in the laminar architecture and retinal degen-
eration were also noted [5,29]. However, abnormal drusen-
like, basal laminar, and basal linear deposits similar to those 
observed in the L-ORD mouse model were not reported in 
rd8 mice [20]. The inferior retina of the rd8 mouse is more 
severely affected with prominent dysplasia than the superior 
retina. These abnormalities were absent in the L-ORD mice 
even at 21 months [20]. These observations indicate that the 
presence of the Crb1 mutation either in the heterozygous 
state or homozygous state did not result in the development 
of the rd8 characteristic phenotype in the Ctrp5+/− mice in our 
L-ORD mouse colony.
The absence of the rd8 retinal phenotype was noted not 
only in Ctrp5+/−; rd8/rd8 mice but also in the littermate Wtrd8/
rd8 mice. This is consistent with the findings reported by 
Mehalow et al. for C57BL/6J mice [5]. In that study, a signifi-
cant proportion of mice with a homozygous Crb1 mutation 
on the C57BL/6J background did not exhibit rd8-associated 
retinal pathology, including ocular spots, retinal folds, pseu-
dorosettes, inner segment shortening, and disorganization [5]. 
A more recent study by Luhman et al. reported that the homo-
zygous rd8 mutation on the C57BL/6 background leads to an 
increase in evenly distributed small discrete autofluorescent 
lesions on SLO fundus images [18].
It was hypothesized that the retinal abnormalities due to 
the Crb1 mutation are strongly modulated by a genetic variant 
expressed in C57BL/6J mice [5]. Supporting this hypothesis, 
Luhmann et al. showed that an autosomal recessive locus in 
C57BL/6 can modulate the rd8 phenotype in mice homo-
zygous for the Crb1 mutation [18,19]. The ES cells used to 
develop our L-ORD mice were a mixed population obtained 
from mice with C57BL/6J and C57BL/6N backgrounds. 
Subsequently, our L-ORD mice were bred with the C57BL/6J 
strain to maintain the mice line. It is likely that the modifier 
allele in the C57BL/6J strain is responsible for the absence of 
the rd8 phenotype in our L-ORD mouse model colony.
The clinical phenotype of Ctrp5+/−;rd8/rd8 and Ctrp5+/−;wt/
wt mice is similar with characteristic late-onset sub-RPE 
deposits and Bruch’s membrane abnormalities including basal 
laminar and basal linear deposits. This pathology is consistent 
with the phenotype observed in patients with L-ORD, while 
the retinal phenotype of age-matched Wtwt/wt and Wtrd8/rd8 mice 
was normal. These observations clearly show that the pres-
ence of the Crb1 mutation did not result in the development 
of retinal abnormalities in either Ctrp5+/−;rd8/rd8 or littermate 
Wtrd8/rd8 mice. In addition, these data demonstrate that the 
S163R mutation in Ctrp5 in the heterozygous state leads to 
the development of the L-ORD phenotype and that the pres-
ence of Crb1 mutation did not alter the retinal phenotype in 
these mice. It is likely that the presence of the Crb1 mutation 
in addition to the Ctrp5 mutation may result in additional 
changes that were not investigated in this study.
The autofluorescent spots reported by Luhman et al. 
in C57BL/6 mice with the Crb1 mutation are similar to the 
















Wt rd8/rd8 7A,9A Absent Absent Absent >200
Ctrp5+/−; rd8/rd8 7B,9B,9C Absent Absent Absent >200
8
Wt ND 6A,6B,7C,9D Absent Absent Absent >200
Ctrp5+/−; rd8/rd8 6A,6B,7D,9E, 9F absent Absent 3±1 >200
12
Wt ND 6A,6B,7E,9G,11 Absent Absent Absent >200
Ctrp5+/−; rd8/rd8 6A,6B,7F,9H,9I,11 Absent Absent 56±7 183±7
15
Wt wt/rd8 6A,6B,7G,9J,11 Absent Absent 15±5 >200
Ctrp5+/−; wt/rd8 6A,6B,7H,9K,9L,11 Absent Absent 80±10 108±7
21
Wt ND 6A,6B,7I,9M,11 Absent Absent 25±4 >200
Ctrp5+/−; wt/rd8 6A,6B,7J,9N,9O,11 Absent Absent >200 15±5
ND: not determined n=number of animals per assessment
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AF lesions observed in Ctrp5+/− mice [18]. It is possible that 
the AF lesions observed in rd8, rd6, Ctrp5, and chemokine-
deficient mice with diverse genetic abnormalities may have a 
similar origin, and studying the pathobiology of these lesions 
may provide better understanding of the mechanism under-
lying RD.
Although this L-ORD mouse model (Ctrp5+/−) generated 
on the C57BL/6J background developed late-onset retinal 
pathology, another knock-in model with the Ctrp5 S163R 
mutation generated on the 129SV background (Ctrp5+/−-129) 
did not develop retinal pathology even when older [30]. 
Shu et al. speculated that the genetic background may also 
influence the development of L-ORD pathology in mice 
[20,30]. Our current studies further support this hypothesis, 
and the identification of the underlying cause of variation in 
the phenotype between these two mouse models is likely to 
assist in understanding the molecular pathology of L-ORD 
and the development of therapeutic interventions to treat this 
condition.
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